Galderma to hold launch event for Alluzience
Pharmaceutical company Galderma is hosting a launch event for its new liquid neuromodulator Alluzience.
Pharmaceutical company Galderma is hosting a launch event for its new liquid neuromodulator Alluzience.
The Dermatologic and Aesthetic Surgery International League (DASIL) World Congress will take place in Mexico City on October 27-30, 2021.
US-based aesthetic training organisation The Aesthetic Society has released its annual Aesthetic Plastic Surgery Statistics for 2020, revealing that Americans spent more than nine billion dollars on plastic surgery.
A survey has indicated that only 22.5% of practitioners follow the recommended protocol for treating headaches with botulinum toxin.
The London Academy of Aesthetic Medicine has launched The Online Ultimate Toxin Course.
US-based medical aesthetic company Evolus Inc has begun a consumer campaign in the US called ‘#NEWTOX NOW’ in the hope to encourage patients to use its botulinum toxin.
The results of two studies conducted by pharmaceutical company Galderma (UK) Limited have demonstrated high patient satisfaction for the use of Azzalure (AbobotulinumtoxinA), its botulinum toxin type A product, in the glabellar complex.
On June 17 Aesthetics Media will be hosting its second webinar in association with pharmaceutical company Galderma UK.
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the marketing authorisation application for Evolus’ botulinum toxin type A formulation.
An examination of the literature and emerging indications by Mr Dalvi Humzah, Professor Andy Pickett and Anna Baker.